LONDON, March 9, 2026 /PRNewswire/ -- The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence ...

Cellular Origins reports that the company completed the first phase of its collaboration with Fresenius Kabi designed to help scale the manufacturing of cell and gene therapies using advanced robotics ...

Increasingly complex cell therapy modalities, including multi-edit knock-in/knockout designs, are accelerating adoption of ...

Key prospects lie in R&D innovation, scaling manufacturing, and CDMO outsourcing, with a strong focus on cell therapies and gene-based interventionsDublin, April 29, 2026 (GLOBE NEWSWIRE) -- The ...

DUBLIN--(BUSINESS WIRE)--The "Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and Regional Analysis - ...

LONDON, May 9, 2023 /PRNewswire/ -- Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach ...

Collaboration with Stanford Medicine establishes a platform manufacturing process and analytics designed to support gene-edited hematopoietic stem cell therapies for HIV and more than 19 rare diseases ...

Cell and gene therapy (CGT) has evolved from a niche research pursuit into a central force in biopharmaceutical innovation. By engineering living cells and genetic material to repair or replace faulty ...

Add Yahoo as a preferred source to see more of our stories on Google. FDA commissioner Marty Makary said eased manufacturing requirements for certain cell and gene therapies were “common-sense reforms ...

The rapid evolution of cell and gene therapy (CGT) is driving unprecedented innovation in manufacturing, yet the adoption of ...

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs ...

Bracco Imaging and Limula, a life science tools company specializing in automated cell and gene therapy manufacturing solutions, launched a R&D project in collaboration with Nicola Vannini, PhD, who ...